TickerFactsScreenerDevelopers

Aprea Therapeutics, Inc. (APRE) — Operating Income

Annual figures by fiscal year, from SEC filings.

2021: -$37.45M2022: -$113.39M2023: -$15.47M2024: -$14.32M2025: -$13.23M-$13.23M
2021Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$13.23M+7.6%
2024-$14.32M+7.4%
2023-$15.47M+86.4%
2022-$113.39M-202.8%
2021-$37.45M—